.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, taking up the ...
.Achilles Therapeutics has wrecked its tactic. The British biotech is actually knocking off on its c...
.Aligos Rehabs is declaring a midstage succeed in metabolic-dysfunction affiliated steatohepatitis (...
.Basilea Pharmaceutica's job developing new antifungals has actually gotten a considerable increase ...
.Having currently gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne mu...
.After pushing back the choice meeting for Applied Therapies' metabolic problem drug govorestat, the...
.Novo Nordisk is proceeding its own push right into genetic medications, accepting to compensate Nan...
.Innovent Biologics has actually made the situation that its gate inhibitor-cytokine combination pro...
.A stage 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate...
.Five months after Rakovina Therapeutics rotated toward expert system, the cancer-focused biotech ha...